Literature DB >> 9358287

Effect of a mistletoe extract (Iscador QuFrF) on viability and migratory behavior of human peripheral CD4+ and CD8+ T lymphocytes in three-dimensional collagen lattices.

G Nikolai1, P Friedl, M Werner, B Niggemann, K S Zänker.   

Abstract

Migration and tissue distribution of immunocompetent cells may be critical prerequisites for efficient immune surveillance. The effect of various concentrations of the mistletoe extract Iscador QuFrF on the locomotory behavior and viability of immunomagnetically isolated human CD4+ and CD8+ T lymphocytes within three-dimensional collagen gels was investigated. Although variation in baseline activities of spontaneously migrating T cells was donor-dependent, a dose-dependent stimulation of the locomotory activity in both CD4+ and CD8+ T cells for noncytotoxic concentrations of Iscador QuFrF (0.25-1.25 micrograms/ml) was detected. The optimal concentration of mistletoe extract and time of maximal response were specific for each donor. As shown by cell tracking and subsequent data analysis, CD4+ T cells exposed to the mistletoe extract displayed a significant increase in mean velocity and time locomoting; total distance migrated was nearly doubled. In contrast, CD8+ T cells showed less pronounced changes in these critical parameters. Cytotoxic effects of the mistletoe preparation on T lymphocytes, which could at least partially be attributed to the induction of apoptosis, were drastically reduced in the presence of fetal calf serum in the culture system. Our data suggest that the direct stimulation of T-cell migration in the presence of mistletoe components may modulate in a dose-dependent manner the system of immune surveillance and recognition in patients under mistletoe therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358287     DOI: 10.1007/s11626-997-0129-8

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  20 in total

1.  Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro.

Authors:  A Stettin; J L Schultze; E Stechemesser; P A Berg
Journal:  Klin Wochenschr       Date:  1990-09-14

2.  Human TH1 and TH2 subsets: doubt no more.

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1991-08

3.  Characterization of cytotoxic proteins from mistletoe (Viscum album L.).

Authors:  M L Jung; S Baudino; G Ribéreau-Gayon; J P Beck
Journal:  Cancer Lett       Date:  1990-05-30       Impact factor: 8.679

4.  Methodological considerations for implementation of lymphocyte subset analysis in a clinical reference laboratory.

Authors:  K A Muirhead; P K Wallace; T C Schmitt; R L Frescatore; J A Franco; P K Horan
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

5.  In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis).

Authors:  O Janssen; A Scheffler; D Kabelitz
Journal:  Arzneimittelforschung       Date:  1993-11

6.  Locomotor phenotypes of unstimulated CD45RAhigh and CD45ROhigh CD4+ and CD8+ lymphocytes in three-dimensional collagen lattices.

Authors:  P Friedl; P B Noble; E D Shields; K S Zänker
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

7.  Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.

Authors:  R Abe; P Vandenberghe; N Craighead; D S Smoot; K P Lee; C H June
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

8.  Molecular mechanism of inhibition of mammalian protein synthesis by some four-chain agglutinins. Proposal of an extended classification of plant ribosome-inactivating proteins (rRNA N-glycosidases).

Authors:  L Citores; J M Ferreras; R Iglesias; M L Carbajales; F J Arias; P Jiménez; M A Rojo; T Girbés
Journal:  FEBS Lett       Date:  1993-08-23       Impact factor: 4.124

9.  Lymphocyte locomotion in three-dimensional collagen gels. Comparison of three quantitative methods for analysing cell trajectories.

Authors:  P Friedl; P B Noble; K S Zänker
Journal:  J Immunol Methods       Date:  1993-10-15       Impact factor: 2.303

10.  Increased secretion of tumor necrosis factors alpha, interleukin 1, and interleukin 6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract.

Authors:  T Hajto; K Hostanska; K Frei; C Rordorf; H J Gabius
Journal:  Cancer Res       Date:  1990-06-01       Impact factor: 12.701

View more
  4 in total

1.  Direct and rapid induction of migration in human CD4+ T lymphocytes within three-dimensional collagen matrices mediated by signalling via CD3 and/or CD2.

Authors:  G Nikolai; B Niggemann; M Werner; K S Zänker; P Friedl
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

2.  COVID-19: General Strategies for Herbal Therapies.

Authors:  Samaneh Soleymani; Ayeh Naghizadeh; Mehrdad Karimi; Azadeh Zarei; Raefeh Mardi; Gholamreza Kordafshari; Niusha Esmaealzadeh; Arman Zargaran
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

3.  Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.

Authors:  Oliver Podlech; Patrick N Harter; Michel Mittelbronn; Simone Pöschel; Ulrike Naumann
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-22       Impact factor: 2.629

4.  Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice.

Authors:  Sonja Schötterl; Stephan M Huber; Hans Lentzen; Michel Mittelbronn; Ulrike Naumann
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-27       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.